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SUMMARY
In th is  thes is ,  the development  of  enzyme- immunoassay
procedures, employíng enzyme- label led antigen, antibody or
hapten,  is  descr ibed.  The pr inc ip le  of  the assay is  the sameas
that of radioimmunoassay, and is discussed in detai l  in Chapter
The enzyme horse-radish peroxidase (Hnp) has been chosen
as a label ,  main ly  because of  i ts  h igh act iv i ty  (a l lowing i ts
detection in ng amounts) and because HRP had already been
coupled to a number of compounds by others. Further reasons for
choosing HRP are given in Chapter 2, together with detai ls of the
structure of HRP and of the reactions it  catalyzes.
Three compounds were coupled to HRP: human chorionic
gonadotrophin (HCG), antibodies to HCG, and oestrogens. In
way, a comparison between different modif ications of the enz
immunoassay could be made. Moreover, the performance of the
test for a small molecule and for a protein could be investigated.
Detai ls of structure and function of the compounds coupled to
HRP are g iven in  Chapter  3.
Chapter 4 reviews the methods described in the l i terature for
coupling. proteins to other proteins and to other substances.
The experimental rnork is described in Chapters 5-7.
In Chapter 5, the development of an ênzyme-immunoassay
HCG using HCG-HRP conjugates is described. The f irst step uas
the production of HCG-HRP conjugates, rntrr ich was accomplished
using glutaraldehyde as a coupling agent. Variat ion of protein
concentrations, glutaraldehyde concentration, t ime, pH and
buffer led to a standard procedure giving optimal results, wfrich
described on p. 59. The conjugates obtained with this procedure
were similar to those obtained with a "tra,o-step'r procedure
adopted from the literature at an advanced stage of the
investigations; the products obtained with the latter method
yielded assays with a somewhat higher sensit ivity.
Sucrose density gradient centri fugation proved a more effective
means of purification for the conjugate preparations than any
other method tr ied.
Optimal incubation condit ions were established for truo sl ightly
different assay procedures, the solid phase and the double
148
ant ibody sol id phase (Dasp) assay. The standard procedures
der ived  are  descr ibed on  p .  74 .
Considerable sensit iv i ty di f ferences appeared to exist  between
so l id  phase and Dasp assays ,  the  la t te r  be ing  a t  leas t  10  t imes as
sensit ive as the former assays. These di f ferences can be
exp la ined in  te rms o f  s te r ic  h indrance.  The de tec t ion  l im i t  o f  the
most sensit ive assay was approx. 1 ng. The assay had a
sat is fac to ry  spec i f  i c i t y  and prec is ion ,  and was used in  p re l im inary
hormone determinat ions  in  u r ine  samples .  The resu l ts  agreed
reasonab ly  we l l  w i th  those ob ta ined by  ex is t ing  methods .
ln  Chapter  6 ,  enzyme- immunoassays  fo r  HCG us ing  an t ibody-
HRP conjugates are descr ibed. The ant ibodies were isolated by
aff  in i ty chromatography and coupled to HRP by means of
g lu ta ra ldehyde.  The con jugates  were  pur i f ied  by  dens i ty  g rad ien t
cent r i fugat ion .  Opt ima l  cond i t ions  were  es tab l i shed fo r  a  "one-
stepi l  and a "two-step" coupl ing procedure. Both types of
conjugate were used for the development of two díf ferent
labe l  led-an t ibody  methods  ( the ' r immunoenzymomet r ic "  and the
t ' sandwich t t  assay) .  These assays  were  less  sens i t i ve  than the
Dasp assay  us ing  HCG-HRP con jugates .  Thus ,  the  la t te r  method
is to be preferred to label led-ant ibody methods.
In  C l 'np ter  7 ,  oes t rogen enzyme- immunoassays  us ing
oestrogen- HRP conjugates are descr ibed. Oestrogen derivat ives
with a carboxyl group were coupled to HRP by a mixed anhydride
reac t ion .  The reac t ion  produc ts  were  pur i f ied  by  dens i ty  g rad ien t
cent r i fugat ion ,  th is  be ing  a  be t te r  pur i f  i ca t ion  method than o thers
that were tr ied. The Dasp method was used for the assay.
The sensit iv i ty of the assay depended on whether or not the
oes t rogen der iva t ives  used in  the  HRP-con jugate  and the
immunogen were  ident ica l .  Homologous assays  (w i th  ident ica l
oes t rogen der iva t ives)  were  up  to  ' Í000  t imes less  sens i t i ve  than
hetero logous  assays  (w i th  non- ident ica l  oes t rogen der iva t ives)  .
The de tec t ion  l im i t  o f  the  most  sens i t i ve  assay  was approx .
5o pg.
ïhe specif  ic i ty of the assay depended on the immunogen used:
a n t i (  1 1 a - O H  o e s t r o g e n  1 1 - s u c c i n y l - a l b u m i n )  y i e l d e d  t h e  m o s t
spec i f  i c  assays .  Assays  w i th  the  des i red  spec i f  i c i t y  fo r  a
par t i cu la r  app l i ca t ion  can be  se lec ted ,  p rov ided tha t  an
appropriate choice of antiserum is made.
Prel iminary experíments with urine samples showed that enzyme.
immunoassay results were in reasonable agreement with the
resul ts  of  a  chemical  assay.
ln conclusion, i t  has been shown that enzyme-immunoassay
can prov ide a s l ight ly  less sensi t ive a l ternat ive to
radioimmunoassay. ïhe stabil i ty of the reagents, the ease of
performance and the simplicity of the required apparatus are al l
points in favour of the enzyme-immunoassay.
Part of these ínvestigatíons has been published previously
(Van Weemen and Schuurs,1971 ,1972) .
